From Wikipedia, the free encyclopedia
Steroidal progestin
Pharmaceutical compound
Metynodiol diacetate Other names Metynodiol diacetate; SC-19198; 11β-Methyletynodiol diacetate; 11β-Methyl-19-norpregn-4-en-20-yne-3β,17α-diyl diacetate; 11β-Methyl-17α-ethynylestr-4-ene-3β,17β-diol diacetate Drug class Progestogen; Progestogen ester IUPAC name(1S,2R,5S,10R,11S,14R,15S,17S)-5-(acetyloxy)-14-ethynyl-15,17-dimethyltetracyclo[8.7.0.02,7.011,15]heptadec-6-en-14-yl acetate
CC1CC2(C(CCC2(C#C)OC(=O)C)C3C1C4CCC(C=C4CC3)OC(=O)C)C
InChI=1S/C25H34O4/c1-6-25(29-17(4)27)12-11-22-21-9-7-18-13-19(28-16(3)26)8-10-20(18)23(21)15(2)14-24(22,25)5/h1,13,15,19-23H,7-12,14H2,2-5H3/t15-,19-,20-,21-,22-,23+,24-,25-/m0/s1
Key:GFIDKNMXIYHURY-YIHNMZODSA-N
Methynodiol diacetate (USANTooltip United States Adopted Name) (developmental code name SC-19198), or metynodiol diacetate, also known as 11β-methyletynodiol diacetate, is a steroidal progestin of the 19-nortestosterone group which was patented in 1968 but was never marketed.[1] It is the diacetate ester of metynodiol, which, similarly, was never marketed.[1]
Progesterone receptor modulators PRTooltip Progesterone receptor AgonistsRetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4